SCM
Soleus Capital Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $618K | Hold |
287,246
| – | – | 0.04% | 89 |
|
|
2025
Q1 | $1.26M | Hold |
287,246
| – | – | 0.09% | 69 |
|
|
2024
Q4 | $1.34M | Hold |
287,246
| – | – | 0.08% | 71 |
|
|
2024
Q3 | $2.02M | Buy |
287,246
+140,000
| +95% | +$983K | 0.16% | 77 |
|
|
2024
Q2 | $1.01M | Buy |
+147,246
| New | +$1.01M | 0.09% | 84 |
|
|
2024
Q1 | – | Sell |
-425,000
| Closed | -$320K | – | 92 |
|
|
2023
Q4 | $320K | Buy |
+425,000
| New | +$320K | 0.04% | 70 |
|
|
2023
Q3 | – | Sell |
-320,000
| Closed | -$509K | – | 92 |
|
|
2023
Q2 | $509K | Buy |
+320,000
| New | +$509K | 0.06% | 95 |
|
|
2022
Q4 | – | Sell |
-5,587,789
| Closed | -$5.31M | – | 73 |
|
|
2022
Q3 | $5.31M | Buy |
+5,587,789
| New | +$5.31M | 0.72% | 41 |
|
|
2021
Q2 | – | Sell |
-99,992
| Closed | -$986K | – | 66 |
|
|
2021
Q1 | $986K | Sell |
99,992
-36,000
| -26% | -$355K | 0.18% | 66 |
|
|
2020
Q4 | $1.47M | Sell |
135,992
-228,357
| -63% | -$2.48M | 0.19% | 45 |
|
|
2020
Q3 | $3.75M | Buy |
364,349
+145,626
| +67% | +$1.5M | 1.99% | 21 |
|
|
2020
Q2 | $4.57M | Sell |
218,723
-95,177
| -30% | -$1.99M | 2.6% | 11 |
|
|
2020
Q1 | $3.07M | Sell |
313,900
-28,900
| -8% | -$282K | 3.57% | 10 |
|
|
2019
Q4 | $3.95M | Buy |
+342,800
| New | +$3.95M | 3.81% | 6 |
|